Chest Meeting
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


COPYRIGHT © 2004 by the American College of Chest Physicians.
This Article
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Salzman, S. H.
Right arrow Articles by Adawi, R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Salzman, S. H.
Right arrow Articles by Adawi, R.

HIV Related Lung Disease


Wednesday, October 27, 2004

12:30 PM - 2:00 PM

Bronchoscopy in the HIV-Infected Patient in the Era of Antiretroviral Therapy: Role of Bronchoalveolar Lavage and Transbronchial Lung Biopsy

Steve H. Salzman, MD, Adam J. Posner, MD* and Rana Adawi, MD

Beth Israel Medical Center, Albert Einstein College of Medicine, New York, NY

PURPOSE: Antiretroviral therapy has reduced the incidence of pulmonary complications of HIV. The use of high-volume, multilobe bronchoalveolar lavage (BAL) has improved the yield for Pneumocystis jiroveci pneumonia (PCP). This study evaluates the role of bronchoscopy in 2000-2002 in comparison to our same-institution data from 1992 (Salzman et al, JBronchology1996;3:88-95).

METHODS: All HIV-infected inpatients who underwent bronchoscopy from 7/00-9/02 were enrolled. Data collected included results of sputum examination, BAL and trans-bronchial biopsy (TBB). Charts were reviewed to determine final diagnoses.

RESULTS: In the 2000-2002 period 147 bronchoscopic procedures were performed in HIV-infected patients, including 27 in mechanically-ventilated patients. Bronchoscopy was diagnostic in 84/147(57%) cases; BAL in 69/147(47%) and TBB in 58/99(59%). TBB was the exclusive source of diagnostic material in 11/99(11%). In 1992, bronchoscopy was more frequently diagnostic, with 162/181(90%) positive (p<0.001). In 2000-2002 PCP was diagnosed in 60(41%) procedures; BAL was positive in 58/60(97%) and TBB was positive in in 45/48(94%). Only 2/48(5%) had PCP established only by TBB. In 1992, TBB was the exclusive positive specimen for PCP in 8/95(8%)(p=NS). For diagnoses other than PCP, in 2000-2002 TBB provided exclusive diagnosis in 9/24(38%). In 1992, TBB provided exclusive diagnosis in 34/55(62%) of non-PCP cases (p<0.05). In 2000-2002, there were 5(3.4%) complications (pneumothorax(2), massive hemoptysis requiring intubation(1), post-procedure intubation(2)). TBB was performed in 6 mechanically-ventilated patients without complication. Pneumothorax post-bronchoscopy occurred only in PCP cases, 2/53 (3.7%).

CONCLUSION: In comparison with 1992, bronchoscopy in HIV-infected patients was perfomed less frequently in 2000-2002 and was less likely to be diagnostic. This is likely due to the lower incidence of opportunistic pulmonary complications due to antiretroviral therapy. The use of large-volume bilobar BAL as standard technique in HIV-infected patients may account for the significanly lower additional yield of TBB in 2000-2002.

CLINICAL IMPLICATIONS: Although the complication rate of bronchoscopy was relatively low (3.4%) in HIV-infected patients, some will choose to use BAL alone. TBB should also be done when non-PCP diagnoses are likely or when BAL is negative on an initial procedure.

DISCLOSURE: A.J. Posner, None.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American College of Chest Physicians.